ONPHOncology Pharma Inc.

About Oncology Pharma Inc. (ONPH)

Oncology Pharma Inc. (ONPH) is a Biotechnology company headquartered in San Francisco, CA, United States whose shares trade over-the-counter on the Expert Market tier.

Oncology Pharma, Inc. is a pioneering oncology company dedicated to licensing, developing, manufacturing and commercializing therapeutics and opportunities within the bio-pharma space. The Company has assembled a team of executives and advisors with a proven multi-disciplinary expertise in the field of cancer therapies, epidemiology and leadership to identify, negotiate and amalgamate "best in class" research, technologies, and drug delivery that are synergistic and collaborative. Oncology Pharma has executed Licensing Agreements with NanoSmart Pharmaceuticals' drug delivery platform, which can target many types of cancer and other diseases;Connect2Med, a powerful application used for recruiting, enrolling and supporting patients for clinical trials. Further information may be found at www.oncology-pharma.com.

Products and services

Research, development, and commercialization of therapeutic drugs and medical devices designed for treatment of many types of cancers.

ONPH key facts

Ticker symbol

ONPH

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

San Francisco, CA, United States

Country of incorporation

US

Year of incorporation

2013

Employees

1

Estimated market cap

$3.9K (as of Apr 15, 2025)

Shares outstanding

38,663,216

Reporting standard

Dark: Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

3/31

Latest filing

Quarterly Report (Dec 31, 2022)

Oncology Pharma Inc. leadership

• George Malasek — Interim CEO

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with O